How They Won It: Irell Nixes Patent For Prenatal DNA Test

Law360, New York (December 3, 2013, 4:28 PM EST) -- Irell & Manella LLP attorneys took aggressive steps to strike down a patent covering a prenatal DNA test licensed by Sequenom Inc. by citing a host of case law holding that natural phenomena and their discoveries cannot be patented to net a win for molecular diagnostics firm Ariosa Diagnostics Inc.

U.S. District Judge Susan Illston ruled in October that Sequenom had applied only routine and well-established scientific procedures to cell-free fetal DNA, or cffDNA, leaving only the naturally occurring genetic matter as the only innovative portion...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.